User profiles for Rachel Chevalier

Rachel Chevalier

Assistant Professor, Children's Mercy Hospital
Verified email at cmh.edu
Cited by 166

Fabrication of sealed nanostraw microdevices for oral drug delivery

CB Fox, Y Cao, CL Nemeth, HD Chirra, RW Chevalier… - ACS …, 2016 - ACS Publications
The oral route is preferred for systemic drug administration and provides direct access to
diseased tissue of the gastrointestinal (GI) tract. However, many drugs have poor absorption …

Picoliter‐volume inkjet printing into planar microdevice reservoirs for low‐waste, high‐capacity drug loading

CB Fox, CL Nemeth, RW Chevalier… - Bioengineering & …, 2017 - Wiley Online Library
Oral delivery of therapeutics is the preferred route for systemic drug administration due to
ease of access and improved patient compliance. However, many therapeutics suffer from low …

Biologic agents are associated with excessive weight gain in children with inflammatory bowel disease

L Haas, R Chevalier, BT Major, F Enders… - Digestive diseases and …, 2017 - Springer
Background Children with active inflammatory bowel disease (IBD) are frequently underweight.
Anti-tumor necrosis factor (anti-TNF) agents may induce remission and restore growth. …

Pharmacogenetic testing for the pediatric gastroenterologist: Actionable drug–gene pairs to know

T Sandritter, R Chevalier, R Abt, V Shakhnovich - Pharmaceuticals, 2023 - mdpi.com
Gastroenterologists represent some of the earlier adopters of precision medicine through
pharmacogenetic testing by embracing upfront genotyping for thiopurine S-methyltransferase …

si RNA Targeting and Treatment of Gastrointestinal Diseases

R Chevalier - Clinical and Translational Science, 2019 - Wiley Online Library
RNA interference via small interfering RNA (si RNA ) offers opportunities to precisely target
genes that contribute to gastrointestinal ( GI ) pathologies, such as inflammatory bowel …

A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens

R Chevalier, T Attard, SL Van Driest… - Expert Opinion on …, 2023 - Taylor & Francis
2. Discussion The majority of PPIs are metabolized into inactive compounds through the action
of hepatic CYP2C19 (major) and CYP3A4 (minor) enzymes. Due to the genetic variants, …

Genomic Insights into Pediatric Intestinal Inflammatory and Eosinophilic Disorders using Single-sell RNA-sequencing

…, E Grundberg, T Pastinen, CA Friesen, R Chevalier… - medRxiv, 2023 - medrxiv.org
Chronic inflammation of the gastrointestinal tissues underlies gastrointestinal inflammatory
disorders, leading to tissue damage and a constellation of painful and debilitating symptoms. …

The evolving landscape of immunotherapy for the treatment of allergic conditions

…, E Adah, B Jones, R Chevalier - Clinical and …, 2023 - Wiley Online Library
Allergic conditions, such as asthma, chronic urticaria, atopic dermatitis (AD), and eosinophilic
esophagitis, have long been treated with oral and topical steroids which resulted in …

[HTML][HTML] Diagnostic role of fractional exhaled nitric oxide in pediatric eosinophilic esophagitis, relationship with gastric and duodenal eosinophils

P Kaur, R Chevalier, C Friesen, J Ryan… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Eosinophilic esophagitis (EoE) is an eosinophilic-predominant inflammation
of the esophagus diagnosed by upper endoscopy and biopsies. A non-invasive and cost-…

[PDF][PDF] Effects of Drug Delivery on PPI-Responsive Esophageal Eosinophilia

A Biller, R Chevalier, A Krasaelap… - 2024 - scholarlyexchange.childrensmercy …
• Eosinophilic Esophagitis (EOE) is an inflammatory condition characterized by infiltration of
eosinophils into the mucosal layer of the esophagus• Symptoms often include painful …